__timestamp | Agios Pharmaceuticals, Inc. | BeiGene, Ltd. |
---|---|---|
Wednesday, January 1, 2014 | 19120000 | 6930000 |
Thursday, January 1, 2015 | 35992000 | 7311000 |
Friday, January 1, 2016 | 50714000 | 20097000 |
Sunday, January 1, 2017 | 71124000 | 62602000 |
Monday, January 1, 2018 | 114145000 | 195385000 |
Tuesday, January 1, 2019 | 132034000 | 388249000 |
Wednesday, January 1, 2020 | 149070000 | 600176000 |
Friday, January 1, 2021 | 121445000 | 990123000 |
Saturday, January 1, 2022 | 121673000 | 1277852000 |
Sunday, January 1, 2023 | 119903000 | 1504501000 |
Monday, January 1, 2024 | 156784000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of BeiGene, Ltd. and Agios Pharmaceuticals, Inc. from 2014 to 2023. Over this period, BeiGene's SG&A expenses skyrocketed by over 21,000%, reflecting its aggressive expansion strategy. In contrast, Agios Pharmaceuticals saw a more modest increase of around 525%, indicating a steadier growth approach.
This data highlights the contrasting strategies of these two companies, offering a fascinating glimpse into their operational priorities and market positioning.
Operational Costs Compared: SG&A Analysis of GSK plc and BeiGene, Ltd.
Cost Management Insights: SG&A Expenses for Biogen Inc. and BeiGene, Ltd.
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Neurocrine Biosciences, Inc.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Insmed Incorporated
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Catalent, Inc.
Comparing SG&A Expenses: BeiGene, Ltd. vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and CRISPR Therapeutics AG
Selling, General, and Administrative Costs: BeiGene, Ltd. vs MannKind Corporation
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Geron Corporation
Selling, General, and Administrative Costs: Alpine Immune Sciences, Inc. vs Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Agios Pharmaceuticals, Inc. Trends and Insights
Selling, General, and Administrative Costs: Arrowhead Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.